Cargando…

Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer

Low vitamin D status is considered as a risk factor for breast cancer and has prognostic significance. Furthermore, vitamin D deficiency increases after adjuvant cancer therapy, which alters bone metabolism increasing the risk of osteoporosis. It is now postulated that vitamin D supplementation in b...

Descripción completa

Detalles Bibliográficos
Autores principales: Anisiewicz, Artur, Pawlik, Agata, Filip-Psurska, Beata, Turlej, Eliza, Dzimira, Stanisław, Milczarek, Magdalena, Gdesz, Katarzyna, Papiernik, Diana, Jarosz, Joanna, Kłopotowska, Dagmara, Kutner, Andrzej, Mazur, Andrzej, Wietrzyk, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743363/
https://www.ncbi.nlm.nih.gov/pubmed/29115583
http://dx.doi.org/10.3892/ijo.2017.4185
_version_ 1783288550839549952
author Anisiewicz, Artur
Pawlik, Agata
Filip-Psurska, Beata
Turlej, Eliza
Dzimira, Stanisław
Milczarek, Magdalena
Gdesz, Katarzyna
Papiernik, Diana
Jarosz, Joanna
Kłopotowska, Dagmara
Kutner, Andrzej
Mazur, Andrzej
Wietrzyk, Joanna
author_facet Anisiewicz, Artur
Pawlik, Agata
Filip-Psurska, Beata
Turlej, Eliza
Dzimira, Stanisław
Milczarek, Magdalena
Gdesz, Katarzyna
Papiernik, Diana
Jarosz, Joanna
Kłopotowska, Dagmara
Kutner, Andrzej
Mazur, Andrzej
Wietrzyk, Joanna
author_sort Anisiewicz, Artur
collection PubMed
description Low vitamin D status is considered as a risk factor for breast cancer and has prognostic significance. Furthermore, vitamin D deficiency increases after adjuvant cancer therapy, which alters bone metabolism increasing the risk of osteoporosis. It is now postulated that vitamin D supplementation in breast cancer treatment delays the recurrence of cancer thereby extending survival. We evaluated the impact of calcitriol and its low-calcemic analogs, PRI-2191 and PRI-2205, on the tumor growth, angiogenesis, and metastasis of 4T1 mouse mammary gland cancer. Gene expression analysis related to cancer invasion/metastasis, real-time PCR, ELISA, western blotting, and histochemical studies were performed. In vitro studies were conducted to compare the effects of calcitriol and its analogs on 4T1 and 67NR cell proliferation and expression of selected proteins. Calcitriol and its analogs increased lung metastasis without influencing the growth of primary tumor. The levels of plasma 17β-estradiol and transforming growth factor β (TGFβ) were found to be elevated after treatment. Moreover, the results showed that tumor blood perfusion improved and osteopontin (OPN) levels increased, whereas vascular endothelial growth factor (VEGF) and TGFβ levels decreased in tumors from treated mice. All the studied treatments resulted in increased collagen content in the tumor tissue in the early step of tumor progression, and calcitriol caused an increase in collagen content in lung tissue. In addition, in vitro proliferation of 4T1 tumor cells was not found to be affected by calcitriol or its analogs in contrast to non-metastatic 67NR cells. Calcitriol and its analogs enhanced the metastatic potential of 4T1 mouse mammary gland cancer by inducing the secretion of OPN probably via host cells. In addition, OPN tumor overexpression prevailed over the decreasing tumor TGFβ level and blood vessel normalization via tumor VEGF deprivation induced by calcitriol and its analogs. Moreover, the increased plasma TGFβ and 17β-estradiol levels contributed to the facilitation of metastatic process.
format Online
Article
Text
id pubmed-5743363
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57433632017-12-29 Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer Anisiewicz, Artur Pawlik, Agata Filip-Psurska, Beata Turlej, Eliza Dzimira, Stanisław Milczarek, Magdalena Gdesz, Katarzyna Papiernik, Diana Jarosz, Joanna Kłopotowska, Dagmara Kutner, Andrzej Mazur, Andrzej Wietrzyk, Joanna Int J Oncol Articles Low vitamin D status is considered as a risk factor for breast cancer and has prognostic significance. Furthermore, vitamin D deficiency increases after adjuvant cancer therapy, which alters bone metabolism increasing the risk of osteoporosis. It is now postulated that vitamin D supplementation in breast cancer treatment delays the recurrence of cancer thereby extending survival. We evaluated the impact of calcitriol and its low-calcemic analogs, PRI-2191 and PRI-2205, on the tumor growth, angiogenesis, and metastasis of 4T1 mouse mammary gland cancer. Gene expression analysis related to cancer invasion/metastasis, real-time PCR, ELISA, western blotting, and histochemical studies were performed. In vitro studies were conducted to compare the effects of calcitriol and its analogs on 4T1 and 67NR cell proliferation and expression of selected proteins. Calcitriol and its analogs increased lung metastasis without influencing the growth of primary tumor. The levels of plasma 17β-estradiol and transforming growth factor β (TGFβ) were found to be elevated after treatment. Moreover, the results showed that tumor blood perfusion improved and osteopontin (OPN) levels increased, whereas vascular endothelial growth factor (VEGF) and TGFβ levels decreased in tumors from treated mice. All the studied treatments resulted in increased collagen content in the tumor tissue in the early step of tumor progression, and calcitriol caused an increase in collagen content in lung tissue. In addition, in vitro proliferation of 4T1 tumor cells was not found to be affected by calcitriol or its analogs in contrast to non-metastatic 67NR cells. Calcitriol and its analogs enhanced the metastatic potential of 4T1 mouse mammary gland cancer by inducing the secretion of OPN probably via host cells. In addition, OPN tumor overexpression prevailed over the decreasing tumor TGFβ level and blood vessel normalization via tumor VEGF deprivation induced by calcitriol and its analogs. Moreover, the increased plasma TGFβ and 17β-estradiol levels contributed to the facilitation of metastatic process. D.A. Spandidos 2017-11-02 /pmc/articles/PMC5743363/ /pubmed/29115583 http://dx.doi.org/10.3892/ijo.2017.4185 Text en Copyright: © Anisiewicz et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Anisiewicz, Artur
Pawlik, Agata
Filip-Psurska, Beata
Turlej, Eliza
Dzimira, Stanisław
Milczarek, Magdalena
Gdesz, Katarzyna
Papiernik, Diana
Jarosz, Joanna
Kłopotowska, Dagmara
Kutner, Andrzej
Mazur, Andrzej
Wietrzyk, Joanna
Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer
title Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer
title_full Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer
title_fullStr Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer
title_full_unstemmed Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer
title_short Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer
title_sort unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4t1 mouse mammary gland cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743363/
https://www.ncbi.nlm.nih.gov/pubmed/29115583
http://dx.doi.org/10.3892/ijo.2017.4185
work_keys_str_mv AT anisiewiczartur unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT pawlikagata unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT filippsurskabeata unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT turlejeliza unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT dzimirastanisław unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT milczarekmagdalena unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT gdeszkatarzyna unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT papiernikdiana unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT jaroszjoanna unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT kłopotowskadagmara unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT kutnerandrzej unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT mazurandrzej unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer
AT wietrzykjoanna unfavorableeffectofcalcitriolanditslowcalcemicanalogsonmetastasisof4t1mousemammaryglandcancer